1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with Graft vs Host Disease in 1 studies
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine: A specific protein kinase C inhibitor, which inhibits superoxide release from human neutrophils (PMN) stimulated with phorbol myristate acetate or synthetic diacylglycerol.
1-(5-isoquinolinesulfonyl)-2-methylpiperazine : A member of the class of N-sulfonylpiperazines that is 2-methylpiperazine substituted at position 1 by a 5-isoquinolinesulfonyl group.
Graft vs Host Disease: The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wepsic, HT | 1 |
| Duffie, GP | 1 |
| Ellis, NK | 1 |
1 other study available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Graft vs Host Disease
| Article | Year |
|---|---|
The effects of protein kinase inhibitors on lymphocyte blastogenesis and GVHD-induced splenomegaly.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Graft vs Host Disease; Immunosuppressive Age | 1989 |